SIGIRR and breast cancer: Since IL-1R8 can negatively modulate the expression of inflammatory mediators in IL-1R-stimulated transformed breast epithelial cells in vitro, we sought to analyze its role on the immune composition in vivo using our transgenic mouse model of breast cancer.